<?xml version="1.0" encoding="utf-8" ?>
<CLASS name="MONOCLONAL ANTIBODIES (EXCEPT ANTI-TNF ALPHA)" code="MONANT">
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>97</SOURCE_FILE>
</SOURCE>
<DRUG name="Belimumab" rxnorm="1092437">
<ATC code="L04AA26" />
</DRUG>
<DRUG name="Bevacizumab" rxnorm="253337">
<ATC code="L01XC07" />
</DRUG>
<DRUG name="Blinatumomab" rxnorm="1597258">
</DRUG>
<DRUG name="Brentuximab" rxnorm="1147320">
</DRUG>
<DRUG name="Canakinumab" rxnorm="853491">
<ATC code="L04AC08" />
</DRUG>
<DRUG name="Cetuximab" rxnorm="318341">
<ATC code="L01XC06" />
</DRUG>
<DRUG name="Denosumab" rxnorm="993449">
</DRUG>
<DRUG name="Ibritumomab" rxnorm="337130">
<ATC code="V10XX02" />
</DRUG>
<DRUG name="Ipilimumab " rxnorm="1094833">
<ATC code="L01XC11" />
</DRUG>
<DRUG name="Natalizumab" rxnorm="354770">
<ATC code="L04AA23" />
</DRUG>
<DRUG name="Nivolumab" rxnorm="1597876">
<ATC code="L01XC17" />
</DRUG>
<DRUG name="Obinutuzumab" rxnorm="974779">
<ATC code="L01XC15" />
</DRUG>
<DRUG name="Ofatumumab" rxnorm="712566">
<ATC code="L01XC10" />
</DRUG>
<DRUG name="Panitumumab" rxnorm="263034">
<ATC code="L01XC08" />
</DRUG>
<DRUG name="Pembrolizumab" rxnorm="1547545">
<ATC code="L01XC18" />
</DRUG>
<DRUG name="Ramucirumab" rxnorm="1535922">
<ATC code="L01XC21" />
</DRUG>
<DRUG name="Rituximab" rxnorm="121191">
<ATC code="L01XC02" />
</DRUG>
<DRUG name="Tocilizumab" rxnorm="612865">
<ATC code="L04AC07" />
</DRUG>
<DRUG name="Trastuzumab" rxnorm="224905">
</DRUG>
<DRUG name="Ustekinumab" rxnorm="847083">
<ATC code="L04AC05" />
</DRUG>
<DRUG name="Vedolizumab" rxnorm="1538097">
<ATC code="L04AA33" />
</DRUG>
</CLASS>
